INVESTIGATING THE NATIONAL DIGITAL CADASTRAL DATABASE (NDCDB) DATA HANDLING WITHIN GIS APPLICATIONS

This paper explains the investigation carried out to understand NDCDB data handling within GIS applications. The method used was a case study replicated to five established GIS applications from different agencies, namely eKadasOnline, SKiP, iPlan, TM SmartMap and DBKL Interactive Portal. The case study was propositioned to the statements of; i) “Such methods of applying NDCDB are because user understands its characteristics”, and ii) “such methods of applying NDCDB are because users know how to adopt it.” Cross-case comparison analysis was then conducted to identify rival findings and explanation building. Based on the evidence of the multi-case study, it was concluded that such methods of adopting NDCDB by the GIS applications administrators and developers were because most of them have a partial understanding of the NDCDB characteristics which led to NDCDB being adopted based on the method that they think were suitable. Recommendations are highlighted in this paper to rectify knowledge-based mistakes found in this study, that included; i) ensuring the NDCDB’s cut-off-date; ii) utilises all existing NDCDB layers; iii) ensure to use the map projection parameters are the authorised and official value; iv) understand that the NDCDB utilises the GDM2000 datum with ITRF2000 epoch 2006; v) False Easting and North Easting can be discarded for geocentric datum; vi) adopting the built-in Geocentric Cassini map projection of GIS software is not advisable; and vii) obtaining relevant additional NDCDB layers. With the recommendations emplace, it is hoped the full potential of NDCDB can be tapped especially for multipurpose cadastre implementation including to ease spatial analysis. Data replication, exhaustion of resources, and reduce risks or costly investments made by decision makers, policy makers, developers or individuals can be avoided when NDCDB is fully optimised for spatial analysis

The analysis of grid independence study in continuous disperse of MQL delivery system

A sustainable cutting method of Minimum Quantity Lubricant (MQL) was introduced to promote lubrication effect and improve machinability. However, its performances are very dependent on the effectiveness of its mist to penetrate deep into the cutting zone. Optimizing the MQL system requires massive experimental work that increases cost and time. Therefore, this study conducts Computational Fluid Dynamic (CFD) analysis using ANSYS Fluent and focuses on the grid independence study in dispersed-continuous phase of MQL delivery system. The main aim is to identify the best mesh model that influences the accuracy of the CFD model. The analysis proposed two different unstructured grid cell elements of quadrilateral and triangular that were only applicable for 2-dimensional fluid flow in CFD. The unstructured grid was controlled with three different mesh quality factors such as Relevance Center, Smoothing, and Span Angle Center at coarse /low, medium, and fine /high. The results showed that the best mesh quality for quadrilateral was at 60,000 nodes number and coarse mesh, whereas the triangular was at 90,000 nodes number and coarse mesh. Both combinations resulted the most consistent and reliable result when compared with past studies. However, this study decided to choose quadrilateral cell element with 60,000 nodes number and coarse mesh as it is considered to be sufficient to provide accurate and reliable result as well as practical in terms of computational time for the MQL model in CFD analysis

Ergogenic, anti-diabetic and antioxidant attributes of selected Malaysian herbs: characterisation of flavonoids and correlation of functional activities

In the present work, aqueous ethanolic (60% ethanol) extracts from selected Malaysian herbs including Murraya koenigii L. Spreng, Lawsonia inermis L., Cosmos caudatus Kunth, Piper betle L., and P. sarmentosum Roxb. were evaluated for their ergogenic, anti-diabetic and antioxidant potentials. Results showed that the analysed herbs had ergogenic property and were able to activate 5'AMP-activated protein kinase (AMPK) in a concentration dependant manner. The highest AMPK activation was exhibited by M. koenigii extract which showed no significant (p > 0.05) difference with green tea (positive control). For anti-diabetic potential, the highest α-glucosidase inhibition was exhibited by M. koenigii extract with IC50 of 43.35 ± 7.5 μg/mL, which was higher than acarbose (positive control). The determinations of free radical scavenging activity and total phenolics content (TPC) indicated that the analysed herbs had good antioxidant activity. However, C. caudatus extract showed superior antioxidant activity with IC50 against free radical and TPC of 21.12 ± 3.20 μg/mL and 221.61 ± 7.49 mg GAE/g, respectively. RP-HPLC analysis established the presence of flavonoids in the herbs wherein L. inermis contained the highest flavonoid (catechin, epicatechin, naringin and rutin) content (668.87 mg/kg of extract). Correlations between the analyses were conducted, and revealed incoherent trends. Overall, M. koenigii was noted to be the most potent herb for enhancement of AMPK activity and α-glucosidase inhibition but exhibited moderate antioxidant activity. These results revealed that the selected herbs could be potential sources of natural ergogenic and anti-diabetic/antioxidant agents due to their rich profile of phenolics. Further analysis in vivo should be carried out to further elucidate the mechanism of actions of these herbs as ergogenic aids and anti-diabetic/antioxidant agents

Conceptual Design of Shielded Metal Arc Welding Workstation: Work Posture and Bead Dimension Consideration

The aim of this study was to propose a conceptual design of SMAW workstation which considered work postures of welders and weld bead dimensions. This study applied full factorial design of experiment. The independent variables were table height, table surface inclination, and work position. Meanwhile the dependent variables were bead height, bead width, and RULA score. Results of analysis of variance showed that the table height, table surface inclination, and work position have an effect on bead width and bead height. This study concluded that the proposed SMAW workstation can offer acceptable bead dimensions when it is designed with adjustable table height, table surface is flat (0°), and work position is standing. However, the work posture still requires further investigation

Enhancing the decolorization of methylene blue using a low-cost super-absorbent aided by response surface methodology

The presence of organic dyes from industrial wastewater can cause pollution and exacerbate environmental problems; therefore, in the present work, activated carbon was synthesized from locally available oil palm trunk (OPT) biomass as a low-cost adsorbent to remove synthetic dye from aqueous media. The physical properties of the synthesized oil palm trunk activated carbon (OPTAC) were analyzed by SEM, FTIR-ATR, and XRD. The concurrent effects of the process variables (adsorbent dosage (g), methylene blue (MB) concentration (mg/L), and contact time (h)) on the MB removal percentage from aqueous solution were studied using a three-factor three-level Box–Behnken design (BBD) of response surface methodology (RSM), followed by the optimization of MB adsorption using OPTAC as the adsorbent. Based on the results of the analysis of variance (ANOVA) for the three parameters considered, adsorbent dosage (X1) is the most crucial parameter, with an F-value of 1857.43, followed by MB concentration (X2) and contact time (X3) with the F-values of 95.60 and 29.48, respectively. Furthermore, the highest MB removal efficiency of 97.9% was achieved at the optimum X1, X2, and X3 of 1.5 g, 200 mg/L, and 2 h, respectivel

Batch isotherm and thermodynamic studies of pineapple (Ananas comosus) plant stem as agricultural biosorbent for the removal of Basic Blue 3 and Congo Red dyes

There are considerable amount of dyes to be discharged in the effluent from dyeing and finishing processes in the textile industry. The discharged dyes are known to be toxic, carcinogenic and mutagenic toward the aquatic system. A low concentration of dyes in the effluent can affect the aesthetic and transparency of water stream. Remaining dyes in the effluent necessitated colour removal along with the stringent restrictions and regulations established. Agricultural waste generally is preferred due to its cost-effective and good performance in adsorption. Pineapple plant stem (PPS) is one of the agricultural residues after shoots transplantation. Utilisation of PPS in dyes removal not only can remediate textile wastewater but also reduce the agricultural waste management problem in Malaysia. In the present study, the performance of pineapple plant stem for cationic (Basic Blue 3, BB3) and anionic (Congo Red, CR) dyes removal has been evaluated in a batch process. The isotherm equilibrium studies indicated that BB3 could be well described by Freundlich model (R² = 0.999) while high correlation values of CR obtained from Langmuir (R² = 0.999) and Temkin (R² = 0.997) models. The maximum sorption capacities for BB3 and CR were found to be 59.52 and 11.92 mg g¯¹, respectively under a favourable sorption process. The dependency of BB3 and CR adsorption on temperature was validated by van’t Hoff equation. The effect of temperature on the BB3 and CR removal by PPS was ascertained by studying the temperature-dependence dyes distribution between bulk solution and adsorbent, and the interaction between dyes and adsorbent. Removal of BB3 and CR by PPS was found to be exothermic. The result suggests that PPS has higher affinity on cationic than anionic dye

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND):a randomised, double-blind, crossover trial

Background: SGLT2 inhibition decreases albuminuria and reduces the risk of kidney disease progression in patients with type 2 diabetes. These benefits are unlikely to be mediated by improvements in glycaemic control alone. Therefore, we aimed to examine the kidney effects of the SGLT2 inhibitor dapagliflozin in patients with proteinuric kidney disease without diabetes. Methods: DIAMOND was a randomised, double-blind, placebo-controlled crossover trial done at six hospitals in Canada, Malaysia, and the Netherlands. Eligible participants were adult patients (aged 18–75 years) with chronic kidney disease, without a diagnosis of diabetes, with a 24-h urinary protein excretion greater than 500 mg and less than or equal to 3500 mg and an estimated glomerular filtration rate (eGFR) of at least 25 mL/min per 1·73 m2, and who were on stable renin–angiotensin system blockade. Participants were randomly assigned (1:1) to receive placebo and then dapagliflozin 10 mg per day or vice versa. Each treatment period lasted 6 weeks with a 6-week washout period in between. Participants, investigators, and study personnel were masked to assignment throughout the trial and analysis. The primary outcome was percentage change from baseline in 24-h proteinuria during dapagliflozin treatment relative to placebo. Secondary outcomes were changes in measured GFR (mGFR; via iohexol clearance), bodyweight, blood pressure, and concentrations of neurohormonal biomarkers. Analyses were done in accordance with the intention-to-treat principle. This study is registered with ClinicalTrials.gov, NCT03190694. Findings: Between Nov 22, 2017, and April 5, 2019, 58 patients were screened, of whom 53 (mean age 51 years [SD 13]; 32% women) were randomly assigned (27 received dapagliflozin then placebo and 26 received placebo then dapagliflozin). One patient discontinued during the first treatment period. All patients were included in the analysis. Mean baseline mGFR was 58·3 mL/min per 1·73 m2 (SD 23), median proteinuria was 1110 mg per 24 h (IQR 730–1560), and mean HbA1c was 5·6% (SD 0·4). The difference in mean proteinuria change from baseline between dapagliflozin and placebo was 0·9% (95% CI −16·6 to 22·1; p=0·93). Compared with placebo, mGFR was changed with dapagliflozin treatment by −6·6 mL/min per 1·73 m2 (–9·0 to −4·2; p<0·0001) at week 6. This reduction was fully reversible within 6 weeks after dapagliflozin discontinuation. Compared with placebo, bodyweight was reduced by 1·5 kg (0·03–3·0; p=0·046) with dapagliflozin; changes in systolic and diastolic blood pressure and concentrations of neurohormonal biomarkers did not differ significantly between dapagliflozin and placebo treatment. The numbers of patients who had one or more adverse events during dapagliflozin treatment (17 [32%] of 53) and during placebo treatment (13 [25%] of 52) were similar. No hypoglycaemic events were reported and no deaths occurred. Interpretation: 6-week treatment with dapagliflozin did not affect proteinuria in patients with chronic kidney disease without diabetes, but did induce an acute and reversible decline in mGFR and a reduction in bodyweight. Long-term clinical trials are underway to determine whether SGLT2 inhibitors can safely reduce the rate of major clinical kidney outcomes in patients with chronic kidney disease with and without diabetes. Funding: AstraZeneca

Evaluation of the Pharmacokinetics and Exposure-Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease

BACKGROUND AND OBJECTIVE: Dapagliflozin, a sodium-glucose co-transporter inhibitor, was originally developed as an oral glucose-lowering drug for the treatment of type 2 diabetes mellitus. Emerging data suggest that cardiovascular and kidney benefits extend to patients without diabetes. Limited pharmacological data are, however, available in patients without diabetes. We aimed to characterise the pharmacokinetic profile of dapagliflozin in patients with chronic kidney disease without type 2 diabetes. METHODS: Plasma samples were collected in a randomised, placebo-controlled, double-blind, cross-over trial (DIAMOND, NCT03190694, n = 53) that assessed the effects of 10 mg of dapagliflozin in patients with a glomerular filtration rate ≥ 25 mL/min/1.73 m2 and proteinuria > 500 mg/day. Mixed-effects models were used to develop a pharmacokinetic model and to evaluate the association between plasma exposure and response. RESULTS: Plasma concentrations (n = 430 observations) from 48 patients (mean age 50.8 years, mean glomerular filtration rate 57.9 mL/min/1.73 m2, median proteinuria 1115 mg/24 h) were best described using a two-compartment model with first-order elimination. Apparent clearance and volume of distribution were 11.7 (95% confidence interval 10.7-12.7) L/h and 44.9 (95% confidence interval 39.0-50.9) L, respectively. Median dapagliflozin plasma exposure was 740.9 ng h/mL (2.5th-97.5th percentiles: 434.0-1615.3). Plasma exposure increased with decreasing kidney function. Every 100-ng h/mL increment in dapagliflozin plasma exposure was associated with a decrease in the urinary albumin:creatinine ratio (β = - 2.8%, p = 0.01), glomerular filtration rate (β = - 0.5 mL/min/1.73 m2, p < 0.01) and systolic blood pressure (β = - 0.4 mmHg, p = 0.03). CONCLUSIONS: The dapagliflozin plasma concentration-time profile in patients with non-diabetic kidney disease appears similar to the profile of patients with diabetic kidney disease described in the literature. Furthermore, the plasma exposure was associated with changes in risk markers for kidney disease

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

The Pierre Auger Observatory Open Data

The Pierre Auger Collaboration has embraced the concept of open access to their research data since its foundation, with the aim of giving access to the widest possible community. A gradual process of release began as early as 2007 when 1% of the cosmic-ray data was made public, along with 100% of the space-weather information. In February 2021, a portal was released containing 10% of cosmic-ray data collected from 2004 to 2018, during Phase I of the Observatory. The Portal included detailed documentation about the detection and reconstruction procedures, analysis codes that can be easily used and modified and, additionally, visualization tools. Since then the Portal has been updated and extended. In 2023, a catalog of the 100 highest-energy cosmic-ray events examined in depth has been included. A specific section dedicated to educational use has been developed with the expectation that these data will be explored by a wide and diverse community including professional and citizen-scientists, and used for educational and outreach initiatives. This paper describes the context, the spirit and the technical implementation of the release of data by the largest cosmic-ray detector ever built, and anticipates its future developments.Comment: 19 pages, 8 figure